Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the drug.
On January 31, the US Federal Trade Commission cleared the merger.
Sun gets RBI nod for transfer of Ranbaxy overseas investments.
India's antitrust regulator has approved Sun-Ranbaxy deal, subject to the companies divesting seven products.
Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries on Tuesday said merger of Ranbaxy with itself has been 'consummated.'
Ranbaxy was asked to sell all products containing Leuprorelin which are marketed and supplied under brand name Eligard.
Torrent to buy Ranbaxy's anti-bacterial generic
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances